Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 EUR | +1.86% | +3.90% | -13.97% |
04-24 | CapMan to Sell Special Transport Group Havator | MT |
04-15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Sales 2024 * | 70.3M 75.17M 103M | Sales 2025 * | 79.47M 84.98M 116M | Capitalization | 348M 372M 508M |
---|---|---|---|---|---|
Net income 2024 * | 22M 23.52M 32.16M | Net income 2025 * | 33M 35.28M 48.24M | EV / Sales 2024 * | 5.66 x |
Net Debt 2024 * | 50.17M 53.64M 73.33M | Net Debt 2025 * | 37.83M 40.45M 55.3M | EV / Sales 2025 * | 4.85 x |
P/E ratio 2024 * |
15.1
x | P/E ratio 2025 * |
10
x | Employees | 200 |
Yield 2024 * |
5.75% | Yield 2025 * |
7.78% | Free-Float | 65.89% |
Latest transcript on CapMan Oyj
1 day | +1.86% | ||
1 week | +3.90% | ||
Current month | +1.76% | ||
1 month | +1.97% | ||
3 months | -13.41% | ||
6 months | -4.60% | ||
Current year | -13.97% |
Managers | Title | Age | Since |
---|---|---|---|
Pia Kåll
CEO | Chief Executive Officer | 44 | 23-03-14 |
Joakim Frimodig
CHM | Chairman | 46 | 15-12-31 |
Atte Rissanen
DFI | Director of Finance/CFO | 37 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
BRD | Director/Board Member | 68 | 21-03-16 |
Director/Board Member | 67 | 19-03-12 | |
Director/Board Member | 58 | 93-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.97 | +1.86% | 108,303 |
24-04-25 | 1.934 | -0.21% | 157,959 |
24-04-24 | 1.938 | +0.62% | 82,116 |
24-04-23 | 1.926 | +0.73% | 77,449 |
24-04-22 | 1.912 | +0.84% | 52,029 |
Delayed Quote Nasdaq Helsinki, April 26, 2024 at 11:29 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.97% | 371M | |
-1.48% | 33.94B | |
+3.65% | 31.94B | |
+6.42% | 5.54B | |
-0.42% | 3.08B | |
+15.23% | 2.98B | |
+22.64% | 2.9B | |
-18.98% | 2.24B | |
+4.02% | 1.23B | |
-2.00% | 1.07B |
- Stock Market
- Equities
- CAPMAN Stock